ID | Term | Allele | Alleles | Background | Color Key |
---|
MP:0002114 | abnormal axial skeleton morphology |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0000428 | abnormal craniofacial morphology |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0001874 | acanthosis |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0001265 | decreased body size |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0000379 | decreased hair follicle number |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0008770 | decreased survivor rate |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0001194 | dermatitis |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0001926 | female infertility |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0002743 | glomerulonephritis |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0001242 | hyperkeratosis |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0005348 | increased T cell proliferation |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0004762 | increased anti-double stranded DNA antibody level |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0003725 | increased autoantibody level |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0002941 | increased circulating alanine transaminase level |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0008577 | increased circulating interferon-gamma level |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0008599 | increased circulating interleukin-2 level |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0008602 | increased circulating interleukin-4 level |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0011440 | increased kidney cell proliferation |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0004801 | increased susceptibility to systemic lupus erythematosus |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0002962 | increased urine protein level |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0001860 | liver inflammation |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0011427 | mesangial cell hyperplasia |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0011164 | panniculitis |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0011102 | partial embryonic lethality |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0011090 | partial perinatal lethality |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0002083 | premature death |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0004947 | skin inflammation |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |
MP:0001212 | skin lesions |
Mta2tm1.1Yzha |
Mta2tm1.1Yzha/Mta2tm1.1Yzha | involves: 129S4/SvJae * C57BL/6 * FVB/N | color key |